Literature DB >> 8891554

Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

C Krüger1, K Höper, R Weissörtel, J Hensen, H G Dörr.   

Abstract

UNLABELLED: In congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, measurement of plasma renin activity (PRA) has been the method of choice in diagnosing salt loss and in monitoring adequacy of mineralocorticoid replacement therapy. Due to methodological problems in PRA determinations, direct immunoradiometric assays for the measurement of active renin concentration have been developed. We measured PRA and active renin concentrations simultaneously in 39 patients with CAH (30 salt-wasting, 9 simple virilizing) to evaluate the potential role of this new method in the management of this disease. PRA was determined with an enzymatic assay (sample volume: 2 x 1000 microliters plasma), active renin concentration with a direct immunoradiometric assay (sample volume: 2 x 200 microliters plasma or serum). We found a highly significant correlation between active renin and PRA in our patients (P < 0.001), as previously shown in healthy subjects. Active renin was as reliable as PRA to assess the quality of mineralocorticoid replacement.
CONCLUSION: In children, active renin determination is preferable to PRA determination because of methodological advantages and a smaller sample volume. It correlates well with PRA and determines the activation of the renin-angiotensin system as precisely as PRA. Active renin determination is useful in the surveillance of mineralocorticoid replacement therapy in CAH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891554     DOI: 10.1007/bf02282834

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

Review 1.  Human prorenin.

Authors:  W A Hsueh; J D Baxter
Journal:  Hypertension       Date:  1991-04       Impact factor: 10.190

2.  Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.

Authors:  P F Plouin; P Cudek; J F Arnal; T T Guyene; P Corvol
Journal:  Horm Res       Date:  1990

3.  An international collaborative study of renin assay: establishment of the international reference preparation of human renin.

Authors:  D R Bangham; I Robertson; J I Robertson; C J Robinson; M Tree
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06

4.  Direct immunometric assay of active renin in human plasma.

Authors:  J Ménard; T T Guyenne; P Corvol; B Pau; D Simon; R Roncucci
Journal:  J Hypertens Suppl       Date:  1985-12

5.  Extraadrenal steroid 21-hydroxylation is not mediated by P450c21.

Authors:  S H Mellon; W L Miller
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Characterization of a monoclonal antibody specific for human active renin.

Authors:  W M Zuo; R E Pratt; C H Heusser; J P Bews; M M de Gasparo; V J Dzau
Journal:  Hypertension       Date:  1992-03       Impact factor: 10.190

7.  Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.

Authors:  G Schaison; B Couzinet; M Gourmelen; F Elkik; P Bougneres
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

8.  Plasma renin activity and plasma prorenin assays.

Authors:  J E Sealey
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

Review 9.  Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.

Authors:  N von Lutterotti; D F Catanzaro; J E Sealey; J H Laragh
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

10.  Plasma 17 alpha-hydroxyprogesterone and aldosterone concentrations in infants and children with congenital adrenal hyperplasia--the role of salt-losing hormones in salt wasting.

Authors:  J H Holcombe; B S Keenan; G W Clayton
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  2 in total

1.  The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase deficiency patients.

Authors:  C M R Germano; M de Castro; J C Crescencio; L Gallo; J Antunes-Rodrigues; A C Moreira; L L K Elias
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

2.  High-dose fludrocortisone therapy was transiently required in a female neonate with 21-hydroxylase deficiency.

Authors:  Yusuke Kawasaki; Takeshi Sato; Satsuki Nakano; Takeshi Usui; Satoshi Narumi; Tomohiro Ishii; Tomonobu Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2022-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.